Israel - English - Ministry of Health

merck serono ltd - cetuximab - solution for infusion - cetuximab 5 mg/ml - cetuximab - cetuximab - erbitux® is indicated for the treatment of patients with epidermal growth factor receptor (egfr) - expressing, ras wild-type metastatic colorectal cancer• in combination with irinotecan-based chemotherapy• in first-line in combination with folfox• as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecanerbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck (scchn)• in combination with radiation therapy for locally advanced disease• in combination with platinum-based chemotherapy for recurrent and/or metastatic disease• as a single agent after failure of platinum-based chemotherapy for recurrent and/or metastatic disease

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck serono ltd - cetuximab - solution for infusion - 5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck serono ltd - cetuximab - solution for infusion - 5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck serono ltd - cetuximab - solution for infusion - 2mg/1ml

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية النابلسي - nabulsi drug store - cetuximab 5 mg/ml - 5 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

merck europe bv, netherlands - cetuximab - solution for infusion - 5 mg/ml

Kenya - English - Pharmacy and Poisons Board

merck healthcare & life science ltd p.o box 38554-00100 nairobi - cetuximab - solution for infusion - 5mg/ml - cetuximab

Kenya - English - Pharmacy and Poisons Board

merck healthcare & life science limited p.o box 38554-00100 nairobi - cetuximab - solution for infusion - 5mg/ml - cetuximab

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

merck europe bv, netherlands - cetuximab - solution for infusion - 5 mg/ml,

Australia - English - Department of Health (Therapeutic Goods Administration)

merck serono australia pty ltd - cetuximab -